Colorectal cancer (CRC) ranks as the third most common cancer globally and is the second leading cause of cancer-related deaths, following lung cancer.
Despite the immune system's capacity for tumor surveillance and elimination, CRC tumors can evade immune responses through complex mechanisms, ultimately escaping immune detection.
T and B lymphocytes play a critical role in adaptive immunity against tumors, with T cells, particularly CD8
